We have already reported the hyperuricemic effects of catecholamine as characterized by inhibition of alpha and beta adrenoceptor antagonists (1, 2) . These effects were due to enhancement of the production of uric acid, but the organs or tissues for its pro duction were not determined.
The liver and the intestines are generally thought to be main organs in the production of uric acid because of the high activity of xanthine oxidase, a rate-limiting enzyme for uric acid production (3) . On the other hand, although the role of uric acid production in tissues other than the liver and intestines is presumed, experiments on the uric acid production have apparently not been carried out using eviscerated rats with or without functional livers, although studies of various plasma components have been reported (4) (5) (6) .
In the present study, eviscerated rats with functional hepatectomy, prepared basically according to the method of Penhos et al. (5) , readily produced uric acid without further metabolization to allantoin, these so-prepared rats proved to be good materials for evaluating drug effects on the production of uric acid in tissues other than the liver and the viscera.
Beta adrenoceptor agonists could produce a marked hyper uricemia even in these animals.
MATERIALS AND METHODS

Drugs:
Drugs administered were potas sium oxonate (Calbiochem), allopurinol (Sigma), 1 -epinephrine (Merck), 1 -norepin ephrine (Sigma) and the following solutions for injection: 1 -isoproterenol hydrochloride (Nikken Kagaku), dl-norepinephrine (San kyo), propranolol hydrochloride (Sumi tomo Kagaku) and phentolamine mesylate (CIBA).
Potassium oxonate and allopurinol were suspended in 1 % gum arabic solution. 1 Epinephrine and 1 -norepinephrine were dis solved with diluted hydrochloric acid and diluted with saline just before use.
Solutions for injection were diluted with saline, if necessary. All agents were usually administered in a volume of 2 ml/kg.
Animals and surgical procedures: Eight week-old, male Wistar strain rats were used, except in the experiments with electrical stimulation in which 17-week-old rats were used.
Evisceration with functional hepa tectomy was done under anesthesia with sodium pentobarbital (50 mg/kg i.p.) basically according to the method of Penhos et al. (5) .
In order to produce functional he patectomy, the coeliac artery was tied and cut together with the anterior mesenteric artery, and the bile duct was ligated and cut with the portal vein. In this operation, the stomach, small and large intestines, pancreas, mesentery and spleen were excised. Ne phrectomy or adrenalectomy was performed, if necessary. Functionally hepatectomized rats without evisceration were prepared as follows: under anesthesia with sodium pentobarbital, the portal vein blood was transferred into the femoral vein at a flow rate of 3.0 ml/min by means of a peristaltic pump (Tokyo Rikaki kai Co.). The operated animals were given 5 ml/kg of 5% glucose solution s.c. every hour, and nephrectomized or adrenal ectomized animals were given 5 ml/kg of saline s.c. in addition to the glucose solution.
Methods Electrical stimulation of the splanchnic nerve: The left splanchnic nerve of evis cerated rats with functional hepatectomy was exposed immediately after the elimination of viscera, and mounted on a bipolar electrode, then the abdominal incision was closed except for the site around the electrode after the exposed nerve had been covered with liquid paraffin.
In these animals, adre noceptor antagonists were administered prior to exposure of the splanchnic nerve. Blood was collected first from the jugular vein just before the electrical stimulation was given and again one hour later. The stimulation with 10-sec rectangular pulses (1 msec, 5 V, 20 c/sec) was given fifteen times at 10-sec intervals, and the stimulation was repeated four times every 15 min. The animals of the control group were given all treatments except the electrical stimulation.
Preparation of tissue extracts and deter mination of enzyme activities:
Tissues were excised immediately after sacrifice by de capitation, then homogenized with nine volumes of 0.05 M phosphate buffer, pH 8.0.
The homogenate was partly used for the determination of urate oxidase activity, and the residue was given the following treatments in order to remove the inhibitors in the determination of xanthine oxidase activity. The homogenate was centrifuged for 10 min at 25,000 x g and recentrifuged after adjust ment to pH 5.0 with 5 N acetic acid. The supernatant fluid was neutralized with 1 N sodium hydroxide, then the volume was adjusted.
A 2-ml portion of the solution was gel-filtrated on a column packed with 15 ml of Sephadex G-25, which was eluted with water. Ten milliliters of eluent was used as the material for the determination of xanthine oxidase activity.
The activities of urate oxidase and xanthine oxidase were estimated basically according to Kalckar's method (8) . The quantitative accuracy of the assay methods, shown in Fig. 1 , was determined using enzyme materials extracted from the liver.
To determine the urate oxidase activity, 1 ml of 0.1 M borate buffer, pH 9.0, was mixed with 0.5 ml of diluted homogenate, and the mixture was preincubated for 10 min at 37'C.
Next, 0.5 ml of 5x10-' M uric acid solution was added, then the mixture was incubated at 37 °C for 10 min. The incubated mixture was mixed with 1.0 ml of 3 N hydrochloric acid, then centrifuged for 10 min at 3,000 r.p.m. The enzyme activity was assessed from the decrease in the optical density at 290 me in the supernatant fluid, and one unit was defined as the enzyme amount which oxidized 1 x 10-° M uric acid per min.
Xanthine oxidase activity was determined using a 0.05 M phosphate buffer, pH 8.0, the eluent from Sephadex G-25 column as the enzyme material and 5x10-4 M xanthine solution as the substrate.
The determination was performed in a manner similar to that for urate oxidase, except for incubation at 37°C for 30 min, and the activity was assessed from the increase of optical density at 290 m;c due to the uric acid produced from xanthine.
The enzyme activity was defined as one unit Blood was cooled in ice water after collection, then the plasma was separated as soon as possible. Uric acid and allantoin were determined by methods described previously (9) . Lactate was estimated by Hohorst's method (10) , and other plasma components were deter mined with an autoanalyzer (TECHNICON autoanalyzer, SMA-MICRO system), in which creatinine and glutamic oxalacetic transami nase were estimated by the method of Chasson et al. (11) and Kessler et al. (12) , respectively. 
RESULTS
The presence of extra-hepatic systems to produce uric acid in rats was confirmed from two points of view. The first was a study on the distribution of xanthine oxidase and urate oxidase in various tissues.
Their ac tivities in all tested materials were assessed as for those in the liver extracts shown in Fig. 1 . As shown in Table 1 , xanthine oxidase activity was found at different levels in various tissues, and particularly at a high level in the liver and the jejunum, whereas urate oxidase activity was recognized only in the liver and was not detectable elsewhere.
The second point of view was confirmed in a study using animals which had undergone functional hepatectomy, with or without evisceration.
As seen in Fig. 2 Subcutaneously administered isoproterenol at a low dose markedly increased the plasma uric acid as shown in Fig. 3 . 
Similar progressive curves of isoproterenol induced hyperuricemia
were observed even when the agent at higher doses was admin istered i.p. to potassium oxonate-treated rats and s.c. to animals with functional he patectomy.
The increments of uric acid and allantoin during one hour after the adminis tration of isoproterenol were compared among the three groups of animals (Fig. 4) The characteristics of catecholamine induced hyperuricemia in eviscerated rats with functional hepatectomy were studied in detail.
In the following experiments, the effects of administered drugs were evaluated by the increment of plasma uric acid during one hour after the administration.
Epinephrine and norepinephrine also induced hyperuricemia in the animals ( Table 2 ), but epinephrine was less active than isoproterenol, and norepin ephrine was the least effective. On the other hand, as seen in Table 4 generally thought to be an important organ in which uric acid is produced. However, the liver, except for that in primates, is also the organ for further metabolism of uric acid to allantoin by urate oxidase.
An earlier study suggested the presence of urate oxidase even in the kidneys and the spleen (14), but we did not detect this activity in tissue extracts other than the liver. On the other hand, xanthine oxidase activity was recognized in various tissues, although it could not be distinguished from that of aldehyde oxidase because of interference from crude materials.
Thus, the presence of an enzyme which can catalyze the metabolism of xanthine to uric acid supports the possibility of production of uric acid in the tissue. The increase of plasma uric acid level without a similar change of allantoin after functional hepatectomy with or without evisceration also supported the presence of extra-hepatic systems for uric acid production.
However, a slight increase in plasma allantoin levels in eviscerated rats with functional hepatectomy and its more apparent increase in functionally hepatectomized animals without evisceration (Fig. 2) may be due to the presence of urate oxidase in tissues other than the liver or renal disturbance in the operated animals.
The degree of increase of plasma uric acid due to evisceration with functional hepatectomy was similar to that in potassium oxonate-treated rats, while that in functionally hepatectomized rats without evisceration was much greater. These results indicate the importance of extra-hepatic systems for uric acid production, but cannot explain the rates of the uric acid production in the liver, the viscera and other tissues, because of various problems based upon experimental conditions in each group of animals.
On the other hand, the hyper uricemic effect of isoproterenol (Fig. 4 ) indicated the importance of the extra-hepatic systems in addition to the hepatic system for uric acid production.
A higher increment of plasma uric acid resulting from the adminis tration of isoproterenol in potassium oxonate treated rats than that in animals with functional hepatectomy suggests that the liver may be important for the uric acid production elicited by isoproterenol. However, an appreciable increment of plasma uric acid in eviscerated rats with functional he patectomy indicated the importance of tissues other than the liver and the viscera in iso proterenol-induced hyperuricemia. On the other hand, functionally hepatec tomized rats without evisceration showed an isoproterenol-induced increment of plasma uric acid less than that in eviscerated rats with functional hepatectomy in spite of the notable increase of plasma uric acid due to the operation. Accordingly, the uric acid pro duction in tissues other than the liver and the viscera is presumed to be important for uric acid production elicited by isoproterenol in extra-hepatic systems.
The hyperuricemic effect of isoproterenol in eviscerated rats with functional he patectomy and nephrectomy, and the effect of allopurinol on isoproterenol -induced hyperuricemia supported the occurrence of a stimulated production of uric acid with administration of isoproterenol.
The different efficiencies among isopro terenol, epinephrine and norepinephrine, and the effect of propranolol characterized the hyperuricemic effect of catecholamine in eviscerated rats with functional hepatectomy as being due to the action of the beta adrenoceptor agonist. The hyperuricemia induced by electrical stimulation of the splanchnic nerve in the operated rats was also blocked by pretreatment with propranolol.
Sumi and Umeda (15, 16) already reported a hyperuricemia by electrical stimulation of the ventromedial hypothalamus in rats. The hyperuricemia was abolished by adre nalectomy and by treatment with propranolol but greatly potentiated by phentolamine.
In our experiments, adrenalectomy had no effect on the increase of plasma uric acid in eviscerated rats with functional hepatectomy, but obviously abolished the hyperuricemia induced by electrical stimulation of the splanchnic nerve. Phentolamine potentiated the hyperuricemic effect of exogenously administered epinephrine but had no effect in the electrical stimulation of the splanchnic nerve. Thus, though the effects of phen tolamine were not always similar, adrenal epinephrine released by nerve stimulation must have produced hyperuricemia due to the action on the beta adrenergic receptor.
Moreover, the present study demonstrated that such a hyperuricemia due to the action of endogenous catecholamine occurred even in eviscerated rats with functional he patectomy. The present study showed the appreciable function of extra-hepatic systems in uric acid production in rats. Das and steinberg (17) recently reported a role of the lung in the hyperuricemic effect of fructose.
The effect of isoproterenol in our experiments on plasma levels of lactate, creatinine and glutamic oxalacetic transaminase similar to that on uric acid in eviscerated rats with functional hepatectomy suggests that the hyperuricemic effect of isoproterenol may be related to its stimulation of energy metabolism in the myocardium or other muscles. Accordingly, the uric acid production in the cardio pulmonary systems or in the skeletal muscle should be studied to fully understand the mechanisms of catecholamine-induced hyperuricemia.
Another important problem is whether the presence of extra-hepatic systems for uric acid production as mentioned above is specific in animals such as rats, and hence the hyperuricemic effect of catechol amine should be investigated even in animals such as chickens with functional hepatectomy.
